When cells were treated with OM, the increased osteogenic differentiation ability induced by RSPO3 knockdown was effectively reversed in the RSPO3 and ERK1/2 double knockdown cells, which was indicated by ALP staining and quantification (Fig. 6B,C). This evidence concerns the gene MAPK3 and ocular melanoma.